Results of antimicrobial susceptibility surveillance in Chile: Consolidating a network;Resultados de la vigilancia de susceptibilidad antimicrobiana en Chile: Consolidando una red

Revista Chilena de Infectologia

Volumn 28, Issue 1, 2011, Pages 19-27

  Silva O , Francisco ^a   Cifuentes D , Marcela ^b   Pinto C , M Eugenia ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

Anti infective agents; Bacterial; Drug resistance; Epidemiology

Indexed keywords

EID: 79953268192     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182011000100004     Document Type: Article

References (21)

1. Rcmpcl O R, Laupland K B. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Hpidemiol Infect. 2009; 137 (12): 1665-73.
2. Conly J. Antimicrobial resistance in Canada. CMAJ 2002; 167: 885-91.
3. Colombo A L, Janini M, Salomao R, Medeiros H, Wey S B, Pignatari A C. Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance. Results from the Division of Infectious Diseases, UNIFHSP. An Acad Bras Cienc 2009; 81 (3): 571-87.
4. Borg M A, Cookson B D, Zarb P, Scicluna H A. on behalf the ARMed Steering Group and Collaborators. Antibiotic resistance surveillance and control in the Mediterranean region: report of the ARMed Consensus Conference. J Infect Dev Ctries 2009; 3 (9): 654-9.
5. Reynolds R, Antimicrobial resistance in the UK and Ireland. J Antimicrob Chemother 2000; 64 (Suppl. 1), i19-i23.
6. While A R, on behalf of the BSAC Working Parlies on Resistance Surveillance. The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model. J Antimicrob Chemother 2008; 62 (Suppl 2): ii3-ii14.
7. Reynolds R, Hope R, Williams L, on behalf of the BSAC working parlies on resistance surveillance. Survey, laboratory, and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 2008; 62 (Suppl 2): ii15-ii28.
8. MacGowan A P, on behalf of the BSAC Working Parlies on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy. J Antimicrob Chemother 2008; 62 (Suppl 2): ii105-ii114.
9. Masterton R. The importance and future of antimicrobial surveillance studies. Clin Infect Dis 2008; 47: S21-31.
10. Hindler J, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007; 44: 867-73.
11. Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data. 2nd ed. Approved guideline M39-A2. Wayne, PA: CLSI, 2006.
12. Bello H, Trabal N, Ibáñez D, Reyes A, Domínguez M, Mella S, et al. Bela-laclamasas de familias diferenles a THM y SHV en cepas de Klebsiella pneumoniae subespecie pneumoniae aisladas en hospilales chilenos. Rev Med Chile 2005; 133: 737-9.
13. Pasleran F, Méndez T, Rapoport M, Guerriero L, Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. J Clin Microbiol 2010; 48 (4): 1323-32.
14. th Informational Supplement. CLSI document M100-S19. Wayne PA: Clinical and Laboratoy Standards Institute; 2009.
15. Rodríguez-Noriega H, Seas C, Guzmán-Bianco M, Mejía C, Álvarez C, Bavestrello L, Zurila J, et al. Involution of melhicillin-resislanl Staphylococcus aureus clones in Latin America. Int J Infect Dis 2010; 14 (7): e560-6.
16. Camponovo R, Susceptibilidad bacteriana a antimicrobianos. Especies aisladas de pacientes ambulatorios de la Región Metropolitana, Chile, 2007. Rev Chil Infect 2009; 26 (1): 18-20.
17. Fica A, Jemenao M I, Bilbao P, Ruiz G, Sakurada A, Pérez, Zúñiga I, et al. Emergencia de infecciones por Enierococcus sp resislenle a vancomicina en un hospital universitario en Chile. Rev Chil Infectol 2007; 24 (6): 462-71.
18. Diomedi A, Blarney R, Juliet C, Fernández A, Garreaud C, Andrade A, et al. Un brole de Enierococcus faecium resislenle a vancomicina, fenolipo Van A (ERV Van A) en el Hospital del Salvador. Descripción, esludio molecular, faclores de riesgo y mancjo epidemiológico. Libro de Resúmenes XIV Congreso Chileno de infeclología. 2007, Pucón, Chile. Resumen CO 17.
19. Soler T, Salamanca L, Arbo G, Molina Ii. In vitro susceptibility of Streptococcus pneumoniae strains isolated from lower respiratory infections in Instilulo Nacional del Tórax (INT). Rev Med Chile 2002; 130 (3): 304-8.
20. Contreras L, Fica A, Figueroa O, Enríquez N, Urrutia P, Herrera P. Resistance to Streptococcus pneumoniae to penicillin and its association with clinical and epidemiological factors. Rev Med Chile 2002; 130 (1): 26-34.
21. CLSI. Performance Standards for Antimicrobial Susceptibility testing eighteenth Informational Supplement. CLSI document M100-S18. Wayne PA: Clinical and Laboratoy Standards Institute; 2008.